The announcement of a new pricing model that is expected to prevent a decline in key business segments is generally seen as a positive development. Investors may view this as a proactive strategy to maintain or improve financial performance in the pharmacy and consumer wellness sectors, which could lead to a positive short-term impact on CVS's stock price.